Literature DB >> 16442501

Angiotensin II inhibits inward rectifier K+ channels in rabbit coronary arterial smooth muscle cells through protein kinase Calpha.

Won Sun Park1, Nari Kim, Jae Boum Youm, Mohamad Warda, Jae-Hong Ko, Sung Joon Kim, Yung E Earm, Jin Han.   

Abstract

We investigated the effects of the vasoconstrictor angiotensin (Ang) II on the whole cell inward rectifier K(+) (Kir) current enzymatically isolated from small-diameter (<100 microm) coronary arterial smooth muscle cells (CASMCs). Ang II inhibited the Kir current in a dose-dependent manner (half inhibition value: 154 nM). Pretreatment with phospholipase C inhibitor and protein kinase C (PKC) inhibitors prevented the Ang II-induced inhibition of the Kir current. The PKC activator reduced the Kir currents. The inhibitory effect of Ang II was reduced by intracellular and extracellular Ca(2+) free condition and by Gö6976, which inhibits Ca(2+)-dependent PKC isoforms alpha and beta. However, the inhibitory effect of Ang II was unaffected by a peptide that selectively inhibits the translocation of the epsilon isoform of PKC. Western blot analysis confirmed that PKCalpha, and not PKCbeta, was expressed in small-diameter CASMCs. The Ang II type 1 (AT(1))-receptor antagonist CV-11974 prevented the Ang II-induced inhibition of the Kir current. From these results, we conclude that Ang II inhibits Kir channels through AT(1) receptors by the activation of PKCalpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442501     DOI: 10.1016/j.bbrc.2006.01.026

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  BKCa and KV channels limit conducted vasomotor responses in rat mesenteric terminal arterioles.

Authors:  Bjørn Olav Hald; Jens Christian Brings Jacobsen; Thomas Hartig Braunstein; Ryuji Inoue; Yushi Ito; Preben Graae Sørensen; Niels-Henrik Holstein-Rathlou; Lars Jørn Jensen
Journal:  Pflugers Arch       Date:  2011-11-04       Impact factor: 3.657

2.  Potentiation of EDHF-mediated relaxation by chloride channel blockers.

Authors:  Cui Yang; Yiu-wa Kwan; Shun-wan Chan; Simon Ming-yuen Lee; George Pak-heng Leung
Journal:  Acta Pharmacol Sin       Date:  2010-09-13       Impact factor: 6.150

Review 3.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 4.  Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth.

Authors:  W F Jackson
Journal:  Adv Pharmacol       Date:  2016-08-17

Review 5.  Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

Authors:  H C Ringvold; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-07-18

6.  Mechanisms underlying angiotensin II-induced calcium oscillations.

Authors:  Aurélie Edwards; Thomas L Pallone
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-18

7.  Acute hypoxia induces vasodilation and increases coronary blood flow by activating inward rectifier K(+) channels.

Authors:  Won Sun Park; Youn Kyoung Son; Nari Kim; Jae-Hong Ko; Sung Hyun Kang; Mohamad Warda; Yung E Earm; In Duk Jung; Yeong-Min Park; Jin Han
Journal:  Pflugers Arch       Date:  2007-05-08       Impact factor: 3.657

Review 8.  Physiological role of inward rectifier K(+) channels in vascular smooth muscle cells.

Authors:  Won Sun Park; Jin Han; Yung E Earm
Journal:  Pflugers Arch       Date:  2008-04-25       Impact factor: 3.657

9.  Complex modulation of the expression of PKC isoforms in the rat brain during chronic type 1 diabetes mellitus.

Authors:  Francesco Vetri; Rafael Chavez; Hao-Liang Xu; Chanannait Paisansathan; Dale A Pelligrino
Journal:  Brain Res       Date:  2012-10-24       Impact factor: 3.252

Review 10.  Potassium channels and uterine vascular adaptation to pregnancy and chronic hypoxia.

Authors:  Ronghui Zhu; DaLiao Xiao; Lubo Zhang
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.